Clinical Scorecard: Linking triglyceride–glucose levels and obesity-related metrics to aortic stenosis risk in individuals with cardiovascular–kidney–metabolic syndrome stages 0–3: findings from a UK Biobank prospective cohort analysis

At a Glance

Key Highlights

• TyG-related indices are associated with 8-24% increased AS risk per 1-SD increment.
• The highest tertile of TyG indices shows a 1.13-1.77-fold increased AS risk compared to the lowest tertile.
• Systolic blood pressure mediates 12.1-18.1% of the association between TyG indices and AS risk.
• TyG-WHtR demonstrates the greatest predictive improvement for AS risk.

Guideline-Based Recommendations

Diagnosis

• Utilize TyG-related indices for early risk stratification of AS in CKM syndrome.

Management

• Implement targeted prevention strategies based on TyG indices.

Monitoring & Follow-up

• Regularly assess TyG levels in patients with CKM syndrome.

Risks

• Monitor for increased AS risk associated with elevated TyG indices.

Patient & Prescribing Data

Individuals with cardiovascular–kidney–metabolic syndrome stages 0–3.

No effective pharmacologic therapies for AS; focus on early identification and intervention.

Clinical Best Practices

• Incorporate TyG indices in routine assessments for CKM syndrome patients.
• Educate patients on the importance of monitoring metabolic health to reduce AS risk.

Related Resources & Content

• UK Biobank Study